Who
Pardeep Nijhawan
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Edesa Biotech.
In numbers
- Trades disclosed
- 109
- Buys
- 19
- Sells
- 0
- Bought
- $593K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 7 Jun 2019
- Last trade
- 5 Oct 2026
- Last filed
- 6 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Oct 2026filed 6 Oct 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | —6,893 at $0.00 | filing |
| 1 Sep 2026filed 1 Sep 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | —5,714 at $0.00 | filing |
| 1 Sep 2026filed 1 Sep 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | —5,714 at $0.00 | filing |
| 3 Aug 2026filed 4 Aug 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | —5,324 at $0.00 | filing |
| 3 Aug 2026filed 4 Aug 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | —5,324 at $0.00 | filing |
| 2 Jul 2026filed 2 Jul 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | —3,378 at $0.00 | filing |
| 2 Jul 2026filed 2 Jul 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | —3,378 at $0.00 | filing |
| 16 Jun 2026filed 16 Jun 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | $800K153,550 at $5.21 | filing |
| 16 Jun 2026filed 16 Jun 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | $800K153,550 at $5.21 | filing |
| 1 Jun 2026filed 1 Jun 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | —1,671 at $0.00 | filing |
| 1 Jun 2026filed 1 Jun 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | —1,671 at $0.00 | filing |
| 27 May 2026filed 29 May 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | —96,913 at $0.00 | filing |
| 27 May 2026filed 29 May 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | —96,913 at $0.00 | filing |
| 1 May 2026filed 1 May 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | —1,159 at $0.00 | filing |
| 1 May 2026filed 1 May 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | —1,159 at $0.00 | filing |
| 1 Apr 2026filed 10 Apr 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | —2,578 at $0.00 | filing |
| 1 Apr 2026filed 10 Apr 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | —2,578 at $0.00 | filing |
| 10 Mar 2026filed 10 Mar 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Bought | $6,5991,000 at $6.60 | filing |
| 10 Mar 2026filed 10 Mar 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Bought | $6,6001,000 at $6.60 | filing |
| 5 Mar 2026filed 6 Mar 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Bought | $39K10,000 at $3.90 | filing |
News
Edesa Biotech Announces FDA IND Clearance for Phase 2 Vitiligo StudyEDSA · elliotlakestandard.ca · 15 Oct 2026Edesa Biotech (NASDAQ:EDSA) Stock Falls 16.2% – Time to Sell?EDSA · themarketsdaily.com · 13 Oct 2026
0 headlines in the last 90 days name Pardeep Nijhawan; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.